03.07.2018 • News

Kamal Abbasi Joins Kamedis’ Board of Director

Kamedis, a provider of products for the treatment of chronic skin disorders, announced the addition of Kamal Abbasi to its board of directors. Abbasi formerly served as area vice president of Nestle Skin Health’s Galderma business for Asia Pacific. He is currently vice president at Sinclair Pharma with responsibility for Asia Pacific, Middle East/North Africa and Central/Eastern Europe.

Abbasi, a British citizen, is a medical doctor and obtained his degree from the Sindh Medical University in Karachi, Pakistan. His appointment coincides with a major growth initiative by Kamedis in Central and Eastern Europe.

Book

Innovation Management in Sustainable Chemistry

Innovation Management in Sustainable Chemistry

Comprehensive resource on sustainable chemistry, bridging the skill gap between academic science education and innovation and entrepreneurship

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.